| Evaluate the Safety and Pharmacokinetics of Ricolinostat (NCT05193851) | Beijing 3E-Regenacy Pharmaceuticals Co., Ltd. | 2022-01-12 |
| A Study to Investigate the Safety and Efficacy of Ricolinostat (NCT05229042) | Beijing 3E-Regenacy Pharmaceuticals Co., Ltd. | 2022-01-01 |
| Pre-study to Evaluate IENFD Induction in Patients With Taxane-induced CIPN (NCT05133947) | Beijing 3E-Regenacy Pharmaceuticals Co., Ltd. | 2021-10-12 |
| Dextrose, Corticosteroids and Surgical Release in Carpal Tunnel Syndrome (NCT04014244) | University Medical Centre Ljubljana | 2021-03-01 |
| The Effects of AFO Heel Height and Stiffness on Gait (NCT04800484) | University of Iowa | 2019-11-07 |
| Technique to Measure Type C Fibre Nerve Conduction Velocitynerve Fibers in Polyneuropathies (NCT03870295) | Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer | 2019-09-30 |
| StimRouter Registry Clinical Protocol (NCT03913689) | Bioness Inc | 2019-06-26 |
| Treatment for Ulnar Neuropathy at the Elbow (NCT03651609) | University Medical Centre Ljubljana | 2019-01-01 |
| Walking Ankle Robot for Foot Drop in Aging and Disabled Populations: A Demonstration Project (NCT03556709) | Baltimore VA Medical Center | 2018-08-01 |
| Seated Ankle Robot for Foot Drop in Aging and Disabled Populations: A Demonstration Project (NCT03530592) | Baltimore VA Medical Center | 2018-06-01 |
| Establishing of Neuronal-like Cells From Patients With Cisplatin-Induced Peripheral Neuropathy (NCT02492360) | Costantine Albany | 2017-12-01 |
| Mitogen Activated Protein Kinase Kinase (MEK1/2) Inhibitor Selumetinib (AZD6244 Hydrogen Sulfate) in People With Neurofibromatosis Type 1 (NF1) Mutated Gastrointestinal Stromal Tumors (GIST) (NCT03109301) | National Cancer Institute (NCI) | 2017-04-07 |
| Chronic Neuropathy Following Chemotherapy (NCT02654691) | Danish Pain Research Center | 2016-06-01 |
| Self-Guided Online Cognitive Behavioral Strategies for Chemotherapy-Induced Peripheral Neuropathy (NCT02760654) | University of Michigan | 2016-04-01 |
| Peripheral Physiological Measures as Determinants of Pain Risk (NCT02985294) | Neuroscience Technologies SLP, Barcelona | 2016-04-01 |
| A Efficacy and Safety Study of Intramuscular Injection of Human Placenta-Derived Cells (PDA-002) in Subjects With Diabetic Peripheral Neuropathy (NCT02552277) | Celularity Incorporated | 2015-10-27 |
| The Effectiveness of Neurodynamic Techniques in Patients With Nerve-Related Leg Pain (NCT01954199) | Federal University of Health Science of Porto Alegre | 2015-03-01 |
| Effect of Physical Therapy in Improving the Health of Patients With Diabetic Peripheral Neuropathy (NCT02115932) | National University Health System, Singapore | 2014-07-30 |
| Effectiveness of Controlled-perturbation Gait Training on Gait Rehabilitation and Fear of Falling in Individuals With Gait Impairments (NCT02031757) | Hadassah Medical Organization | 2013-12-01 |
| Dietetic and Hygiene Measures in Metabolic Neuropathies: the Neurodiet Study (NCT01465620) | Henri Mondor University Hospital | 2011-11-01 |
| Study of Ranexa in Patients With Coronary Artery Disease and Painful Polyneuropathy (NCT00832572) | Gilead Sciences | 2009-01-01 |
| Study of NGX-4010 for the Treatment of Painful HIV-Associated Neuropathy (NCT00321672) | NeurogesX | 2006-06-01 |
| Study of NGX-4010 for the Treatment of Postherpetic Neuralgia (NCT00300222) | NeurogesX | 2006-03-01 |
| Effect of Exercise on Gait and Balance in Peripheral Neuropathy (NCT00270842) | US Department of Veterans Affairs | 2006-01-01 |
| Study of NGX-4010 for the Treatment of Painful HIV-Associated Neuropathy (HIV-AN) or Postherpetic Neuralgia (PHN) (NCT00233155) | NeurogesX | 2005-08-01 |
| Study of NGX-4010 for the Treatment of Postherpetic Neuralgia (NCT00115310) | NeurogesX | 2005-06-01 |
| Study of NGX-4010 for the Treatment of Painful HIV-Associated Neuropathy (NCT00064623) | NeurogesX | 2003-08-01 |
| Marijuana for HIV-Related Peripheral Neuropathy (NCT00046722) | Center for Medicinal Cannabis Research | 2003-01-01 |
| Pilot Study of High-Dose Capsaicin Patches to Treat Postherpetic Neuralgia Pain (NCT00034710) | NeurogesX | 2002-03-01 |
| Neotrofin for Treatment of Chemotherapy-Induced Peripheral Neuropathy (NCT00041795) | NeoTherapeutics | 2002-01-01 |
| An Open-Label Extension Study of NGX-4010 for the Treatment of Neuropathic Pain (NCT00089557) | NeurogesX | |
| NGX-4010 for the Treatment of Postherpetic Neuralgia (NCT00061776) | NeurogesX | |
| Acetyl-L-Carnitine for the Treatment of NRTI-Associated Peripheral Neuropathy (NCT00050271) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Tolerability of Three Local Anesthetic Formulations in Conjunction With NGX-4010 for the Treatment of Neuropathic Pain (NCT00082316) | NeurogesX | |